US Patent Issued to The Trustees of the University of Pennsylvania, Novartis on Feb. 3 for "Immune-enhancing RNAs for combination with chimeric antigen receptor therapy" (Pennsylvania Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,308, issued on Feb. 3, was assigned to The Trustees of the University of Pennsylvania (Philadelphia) and Novartis AG (Basel, Switzerland).

"Immune-enhancing RNAs for combination with chimeric antigen receptor therapy" was invented by Lexus R. Johnson (Philadelphia), Carl H. June (Merion Station, Pa.) and Andy J. Minn (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating diseases such as cancer. The invention also relates to a method of administering a chimeric antigen receptor (CAR) therapy and an additional therapeutic agent."

The patent was filed on Jan. 8, 2019, under Application...